Billiontoone Inc (BLLN) Stock Price, Quote & News

Company Profile

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a l...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: (650) 460-2551

Website: www.billiontoone.com

Address:

1035 O’Brien Drive, Menlo Park, United States

Reanimated666 May. 21 at 1:02 PM

$BLLN Am I wrong or does it look as if this stock is about to crash hard

1 · Reply

Reanimated666 May. 18 at 1:01 PM

$BLLN $ILMN patents infringement If found guilty billion to nil

0 · Reply

Reanimated666 May. 15 at 11:27 PM

$BLLN

0 · Reply

Bazzzigar May. 14 at 5:35 PM

$BLLN

0 · Reply

Walknastie May. 14 at 2:06 AM

$BLLN “Defendant BillionToOne, Inc. (‘BillionToOne’) has built its business, including its flagship UNITY Screen, by misappropriating and infringing foundational genomic technologies developed and patented by Illumina.”

1 · Reply

Amb8675309 May. 12 at 5:40 PM

$BLLN another prediction: once they settle out of court with ILMN, ILMN will want a licensing percentage of all the tests they’ve already done for whatever period it is they’re being sued for. So you’re most likely going to see an announcement of a one time payment to ILMN for those tests, PLUS they now they have to pay a percentage licensing fee going forward, on every test. This is in today’s environment where payors are paying less in general, reimbursement wise, on tests. So be careful of “spin” during earnings calls where they brag about testing volume- reality is if amount reimbursed per test is falling, plus now ILMN gets a percentage on each test… not a business to be in anymore…

4 · Reply

Amb8675309 May. 12 at 5:31 PM

$BLLN they’ve been selling their test for years- IP owned by Illumina- they’ve got a deep hold on patents- probable end result- a licensing deal which will take a bite out of already decreasing margins due to payors decreasing reimbursement amounts. This will settle out of court. Look up all the companies that Illumina has already sued. CEO is hard headed to think this wasn’t coming once he went public and started to steal market share in the NIPT space…

1 · Reply

Amb8675309 May. 12 at 5:18 PM

$BLLN look in my timeline for BLLN- I called it re lawsuits- thought NTRA would be the one- looks like Illumina- infringement on IP

2 · Reply